Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Targeting Immune Dysregulation in Childhood Evans Syndrome

Amanda Bell Grimes, MD, Taylor Kim, MD, Susan E. Kirk, PA-C, Michele P. Lambert, MD, Rachael F. Grace, MD, Jenny M. Despotovic, DO, MS

Blood (2018) 132 (Supplement 1): 3564.

https://doi.org/10.1182/blood-2018-99-110734

Published: 2018

Journal Articles

The Un-BLyS-Ful State: Blocking Factor VIII Inhibitor Development with BLyS Depletion

Bhavya S Doshi, MD, Robert J. Davidson, BS, Valder R Arruda, MD PhD

Blood (2018) 132 (Supplement 1): 138.

https://doi.org/10.1182/blood-2018-99-114795

Published: 2018

Journal Articles

Cyclical Thrombocytopenia— a Rare but Fatal Imitator of Idiopathic Thrombocytopenia

Shazia Samanani, MD, Shrinkhala Khanna, MD, Rehan Mujahid, Armen Asik, MD

Blood (2017) 130 (Supplement 1): 4860.

https://doi.org/10.1182/blood.V130.Suppl_1.4860.4860

Published: 2017

Journal Articles

Belimumab, a Neutralizing BAFF (B Cell Activating Factor) Antibody, Enhances the Susceptibility of Chronic Lymphoid Leukemia (CLL) Cells to Abt-199 Treatment

Jonas Schmidt, MD, Julia Wild, MSc, Benedikt Strunz, MD, Lothar Kanz, MD, Helmut R Salih, MD

Blood (2015) 126 (23): 2947.

https://doi.org/10.1182/blood.V126.23.2947.2947

Published: 2015

Journal Articles

Activation-Induced Release of the TNF-Family Member BAFF By NK Cells Facilitates Resistance of Chronic Lymphoid Leukemia Cells to Direct and Rituximab-Induced NK Lysis

Julia S Wild, Stefanie Raab, MSc, Benjamin J Schmiedel, PhD, Andreas Maurer, Pascal Schneider, PhD, Lothar Kanz, MD, Helmut R Salih, MD

Blood (2014) 124 (21): 1963.

https://doi.org/10.1182/blood.V124.21.1963.1963

Published: 2014

Journal Articles

Single Cell Network Profiling (SCNP) Reveals Race-Associated Differences in B Cell Receptor Signaling Pathway Activation

Diane Longo, Ph.D., Brent Louie, Ph.D., Kavita Mathi, MD, Zoltan Pos, PhD, Ena Wang, M.D., Rachael E. Hawtin, Ph.D., Francesco Marincola, M.D., Alessandra Cesano, M.D., Ph.D.

Blood (2011) 118 (21): 1125.

https://doi.org/10.1182/blood.V118.21.1125.1125

Published: 2011

NARROW

Targeting Immune Dysregulation in Childhood Evans Syndrome

The Un-BLyS-Ful State: Blocking Factor VIII Inhibitor Development with BLyS Depletion

Cyclical Thrombocytopenia— a Rare but Fatal Imitator of Idiopathic Thrombocytopenia

Belimumab, a Neutralizing BAFF (B Cell Activating Factor) Antibody, Enhances the Susceptibility of Chronic Lymphoid Leukemia (CLL) Cells to Abt-199 Treatment

Activation-Induced Release of the TNF-Family Member BAFF By NK Cells Facilitates Resistance of Chronic Lymphoid Leukemia Cells to Direct and Rituximab-Induced NK Lysis

Single Cell Network Profiling (SCNP) Reveals Race-Associated Differences in B Cell Receptor Signaling Pathway Activation

Email alerts

ASH Publications

American Society of Hematology

Targeting Immune Dysregulation in Childhood Evans Syndrome

The Un-BLyS-Ful State: Blocking Factor VIII Inhibitor Development with BLyS Depletion

Cyclical Thrombocytopenia— a Rare but Fatal Imitator of Idiopathic Thrombocytopenia

Belimumab, a Neutralizing BAFF (B Cell Activating Factor) Antibody, Enhances the Susceptibility of Chronic Lymphoid Leukemia (CLL) Cells to Abt-199 Treatment

Activation-Induced Release of the TNF-Family Member BAFF By NK Cells Facilitates Resistance of Chronic Lymphoid Leukemia Cells to Direct and Rituximab-Induced NK Lysis

Single Cell Network Profiling (SCNP) Reveals Race-Associated Differences in B Cell Receptor Signaling Pathway Activation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only